Author

The Breadwinner

Browsing

As of September, America’s rents were up 10.2% on a country-wide level compared to where they were the previous year. So, if your lease is expiring soon, your landlord might attempt to increase your rent. If you are worried that will happen, here are some important steps to take.

1. See how much of an increase you can afford

Maybe you are currently spending $1,000 each month on rent, and you are convinced your landlord will increase that to $1,100 once your lease is due. If that is an amount you could afford to spend, you might not need to panic.

Take a look at what your budget is to see if you have any wiggle room. If you are getting a raise next year but have an expiring lease in Feb., your higher paycheck might take effect before your housing costs increase, making a rent hike more manageable.

It also would not hurt to look at your savings account. If you cannot really afford a rent hike based on your salary but you love where you’re living and don’t want to relocate, dipping into your savings a little might not be unreasonable.

As a general rule, your income should cover all of your living expenses. But if it means staying in your home after a rent hike would include spending your whole paycheck and still ending up about $30 short every month, you might be okay to reach into savings a little if you have a lot of money socked away.

Right now, rents are up all across the board, but they might decrease in the future. So, you could tap your savings account to get through it, that is not a terrible thing if the cash is there and you have enough left over for any emergencies that may arise.

2. Talk to your landlord before accepting a new lease

Your landlord might have every intention of increasing your rent. But if you make it clear that is something you truly cannot afford, your landlord may reconsider — especially if you are a respectful tenant who has been paying the rent on time consistently.

Your landlord might also be willing to negotiate how much of an increase to your rent you will have to pay. Say your landlord’s plan is to increase your rent by $60 each month. If you explain that your income just cannot cover that much, your landlord might agree to a $30 raise instead.

3. Look into your moving options

If you are convinced your rent will be increased to a point where you just can’t afford it, now is the time to start searching for other rentals. It might be the case that relocating to a different home will do the trick of helping you find an affordable lease. Or you might need to look at downsizing your living space.

If you don’t have much furniture and you have helpful friends with large vehicles, you might be able to move for free.

Soaring rent prices can burden a lot of renters whose leases are coming up, especially when everyday costs like gas and groceries are also up. If you think you are in line for a rent increase, take these steps to make a plan that will help minimize that blow.

Author: Blake Ambrose

Most of the time, when traders build a portfolio consisting of dividend stocks, they will compromise on growth. But if traders look closely, there are several growth stocks that can also be great dividend stocks. Maybe the best example is Apple, which is a stock that coincidentally might be a great investment idea for 2022.

The tech giant is dishing out heaps of free cash flow and paying a significant dividend, but it is also growing fast– and its large business growth looks set to continue for some time.

Apple’s seemingly attractive dividend

Apple’s dividend seems extremely durable and will likely continue growing. Supporting the company’s $14.5 billion in yearly dividend payments is $93 billion in trailing 1 year free cash flow. This means that only about 16% of the company’s free cash flow, or cash that’s provided by operations after capital expenditures are taken out, is paid out in dividends.

With a small portion of Apple’s free cash flow going back into dividends, this dividend is not only sustainable amid any challenges that may arise, but also might even continue rising. Apple’s most recent dividend raise was earlier in the year when the business increased its quarterly dividend payout by 7%.

The dividend boost was below the company’s normal average yearly dividend raise (closer to 10%), likely reflecting the uncertainty within the environment the business was operating in as logistical challenges and supply shortages were just beginning to surface in a large way. It is likely that Apple’s dividend growth rates in the future will be much closer to its historical growth rates.

A growth stock and a dividend stock?

The good thing about Apple is that its shares also have strong prospects for stock-price appreciation over the long term.

Despite Apple’s trailing-1-year revenue growth of 33% and its net earnings roaring 65% higher during this same time period, Shares of Apple is currently trading at just 31 times earnings. There is good reason to believe Apple will have more robust growth in the future, which makes this look like an even more conservative valuation.

For example, consider just one of Apple’s numerous growth catalysts which is its services business. Apple’s Gross profit from its services business in year 2021 was around $48 billion — which was up 31% year over year and accounted for almost a third of Apple’s total gross profit. Since this company segment grows consistently and is not very dependable on year-to-year product releases, there is no reason to think this segment’s contribution to Apple’s gross profit will slow down rapidly. Any deceleration will most likely be slow.

Of course, there are some other growth drivers, as well. In fact, Apple has had strong growth in every geographic and product segment — and Apple’s efforts in headphones, wearables, and smart speakers are just getting started.

Altogether, Apple’s fast business growth, strong dividend possibilities, and a conservative valuation help make the tech giant a great stock with a good chance at performing lucratively over the long term.

Author: Scott Dowdy

There is no denying that this year has been a difficult year for the biotech market. The shares of quite a few small and big biotech businesses alike are set to start the year in negative territory. However, those disappointing performances will not necessarily be extended into the future.

Here are two stocks that had a bad year in 2021 but might soar in 2022.

Long-term catalysts ahead for this biotech

Shares of Axsome Therapeutics have fallen by over 50% in 2021. The company has had several setbacks. With the largest setback being the review of Axsome Therapeutics’ top pipeline candidate, AXS-05, which was postponed. The FDA was scheduled to finish its review of the possible therapy for a depressive disorder in late Aug.

But the agency found issues in Axsome Therapeutics’ application. Because of this, the FDA has yet to have the drug approved. While this problem hurt its stock performance, the future does look bright for the company. AXS-05 has proved effective at reducing some symptoms of depression during a late-stage study.

The demand for a medicine like AXS-05 has risen as a result of the Covid-19 pandemic, with the number of individuals suffering from depression increasing to 80 million since the beginning of the outbreak. AXS-05’s delayed review is not ideal. But given the great results it has delivered in clinical trials and the high demand for more depression therapies, it will eventually hit the market.

But Axsome Therapeutics is also creating several other drugs. These include AXS-07, a possible treatment for migraines, and AXS-14 and AXS-12, aimed at treating fibromyalgia and narcolepsy, respectively. The company predicts the potential yearly sales of these therapies to be between $4 billion to $9 billion.

Axsome Therapeutics has a market cap of about $1.4 billion and is less than 50% of the lower end of these predictions. That gives the company a massive upside potential. Naturally, some risks are involved; the company might run into more regulatory setbacks for AXS-05 or some other pipeline candidate.

But on the bright side, if the company begins racking up on regulatory approvals for all of its therapies, its share price will skyrocket in 2022 and the years to come. While I would not suggest going all-in on Axsome Therapeutics — it would be best to begin with a small position, for now it seems 2022 will be a much better year for the company.

Ready for take off

Recently trades have been moving away from higher-priced growth stocks and into a more value-oriented investments. Novartis is One stock that has benefited from that, which has gone up over 5% in the last month while the S&P 500 has dropped 2%. The drug maker’s shares are still down 9% so far this year. However. if the shift to value shares continues, Novartis might continue climbing in 2022.

The company itself is in great shape. Novartis announced a profit of $9.8 billion on sales of $52.4 billion over the last year, good for a profit margin of just below 19%. It has also produced a lot of money, with free cash flow in that time coming in at $12.2 billion. And the business is getting even more money into its financials after it sold its stake in drug maker Roche for $20.7 billion. Because of this large amount of cash, the business is planning to purchase back up to $15 billion worth of its stock by the end of 2023.

Cash is king, and Novartis is collecting plenty of it recently. That will give the business a lot of flexibility moving into the future if it wanted to pursue an acquisition or invest in growing its company in other ways. The expectation is that through new approvals and products its company can keep growing sales by at minimum 4% each year until 2026.

Currently, the stock is trading at about 20 times earnings. That is ideal given that the avg. healthcare stock is trading at a multiple of over 25. And Novartis’ dividend yield of 3.8% helps make the stock seem even more lucrative to long-term investors. The avg stock on the S&P 500 is paying a dividend that yields just 1.3%. I am confident that as traders begin to focus more on value in 2022, Novartis might become one of the more popular stocks to own.

Author: Blake Ambrose

The case for NFTs

The NFT market has what it takes to be massive. Whether it’s a piece of artwork, a tweet, or a baseball card almost anything can be digitized. It is estimated by JPMorgan Chase that these digital art items produce $2 billion in sales each month — which is five times the amount that they were bringing in at the beginning of 2021.

The top bank stated, “by making marketplaces for illiquid assets like music, digital art, gaming, collectibles, and other assets, the NFT world is set to continue growing over the years to come because it contributes to solving the problem of injecting liquidity into illiquid assets like collectibles.” Based on estimates from Cointelegraph, NFT sales may hit $17.7 billion in 2021 which would be a record.

NFTs will become more liquid as they become more mainstream, this will make it easier to buy and sell them. There are lots of marketplaces out there. OpenSea is among the most popular ones to sell and buy digital items. Your own NFTs can be created to sell on these platforms.

There are not many NFT stocks, however the Defiance Digital Revolution is a new exchange-traded fund. It was launched this month and focuses on crypto, blockchain, and NFTs.

The case for cannabis

Cannabis stocks are much like NFTs with their volatile swings in value. They are not an investment that is risk-free. Marijuana is still illegal in the United States at the federal level, and that makes it hard for businesses to get money to help them grow. Multi-state operators can not trade on the big exchanges and having bank services is a challenge also. Even with these obstacles, the sector has grown. The cannabis industry is more evolved than the NFT market, because of this there are more ways for investors to gain exposure to it.

Investors can purchase shares of Trulieve Cannabis, a top cannabis producer, which is on track to make more than $1 billion in revenue next year and is also profitable. There is more room for cannabis producers to grow as more states and countries make marijuana legal. It is projected that by 2026, the global cannabis market may be worth more than $90 billion, while growing at a compound yearly rate of 28% until then.

If investing in a producer is too risky for you, you can always purchase shares of a dividend-producing real estate investment trust like Innovative Industrial Properties, which rents out the places to cannabis businesses. There are also pick-and-shovel investments like Grow Generation and Agrify that provide cannabis producers with the solutions and tools to grow their crops.

Which one is better?

NFTs are very speculative and it can be hard to decide how much a digital item is worth. Physical paintings are hard in themselves to value, let alone digital items. Cannabis is a more stable investment because you can invest in businesses that are generating profits, and it is easier to see how the business will increase its value. With NFTs, there’s greater risk and uncertainty involved. You may get lucky and make a profit selling and buying a NFT, but the safer choice for 2022 is without a doubt the cannabis sector.

Author: Scott Dowdy

Next year might not have the runaway home-price growth that 2021 saw, but some markets are set to see prices increase significantly next year.

A survey was conducted be the National Association of Realtors of over 20 housing and economic experts to gauge their predictions of inflation, interest-rate movements and home-price growth in the year ahead. The group expects that median home prices will increase by 5.7% next year, compared with an overall 4% rate of inflation.

Meanwhile, these experts think the Federal Reserve will hike interest rates twice by 0.25%. this week, the Central Bank stated it was expecting three interest-rate hikes in 2022, as well as three more in 2023 and two more in 2024.

Depending on whether the Fed’s recent projection holds true, the speed of home-price growth might be even lower in 2022.

“Slowing price growth will play a role in the interest rate hikes put in place by the Federal Reserve,” Lawrence Yun, said. Increased rates will slow down home sales, which Yun expects will fall to 5.9 million from the yearly rate of 6 million that has been estimated for all of 2021.

Some undervalued housing markets might attract buyers in 2022

Amid this backdrop, though, the National Association of Realtors predicts some housing markets will see bumper price increases. The organization’s economists made a list of 10 “hidden gem” housing markets where price appreciation will be faster than the national avg. These markets include the following: Dallas-Fort Worth, TX, Daphne-Fairhope-Farley, AL, Fayetteville-Springdale-Rogers, Ark.-Mo, Huntsville, AL, Knoxville, TN, Palm Bay-Melbourne-Titusville, FL, Pensacola-Ferry Pass-Brent, FL, San Antonio-New Braunfels, TX, Spartanburg, S.C, Tucson, Arizona.

“Several markets did fairly well this year, but not as strong as expected,” Yun said. “Therefore, next year, these ‘hidden gem’ markets have even more room for growth.”

Aside from location — all 10 markets are located in the South or the Sun Belt regions — these housing markets share some other similarities. The markets were thought to be undervalued, which means that the ratio of median home prices to median household incomes was at the low end of the spectrum for the almost 400 markets that the organization studied.

Economists also factored in things such as domestic migration, broadband service and population growth, in identifying the undervalued markets.

“We think we are still going to see a large amount of activity in the Mountain West region,” Danielle Hale, economist at Realtor.com, stated during a real-estate forecast summit that was hosted by the National Association of Realtors this week. “But it isn’t just in the Mountain West — we also think there will be pockets in the South, New England, and in the Midwest where affordable homes really help incentivize homeownership.”

Other economists, though, had a less upbeat outlook on price growth in the markets that have seen large demand from home buyers in recent years.

Ken Johnson, who is a professor at Florida Atlantic University and a real-estate economist, said his data has shown decreasing premiums for houses in the West and a slowdown within those markets. Overall, he warned that buyers should look at whether homeownership is the best way to grow their wealth.

“We are near the height of the current cycle,” Johnson explained during the Realtors summit. “It does not always seem smart to buy near the top of the cycle when it’s possible for you to be renting and reinvesting.”

Author: Steven Sinclaire

1. The index fund portfolio

The average long-term growth rate of the S&P 500 is around 7% after inflation. Your $640 contribution every month would increase to $1 million in 35 years, at this rate.

Then, add your employer’s matching contributions to your $640 a month, and you will reach 7 figures a lot faster. A matching contribution of $340 a month will get you to millionaire rank in less than 30 years.

Achieving market-level returns: What is exciting with this is that you can invest straight to the S&P 500 to make those market-level returns. An S&P 500 index fund is the same as the S&P 500’s performance, with only a small drag to handle fund expenses. Pick a fund with a very low expense ratio, and the returns should be a notch under the index.

Limiting volatility in your portfolio: Even though the S&P 500 averages 7% yearly growth over long time periods, the short-term performance can be unstable. If you invest all of your contributions in an S&P 500 fund, the balance in your portfolio will show the full strength of the market’s downs and ups. It can be stressful to watch.

You can match your S&P 500 fund with a more stable security, like a United States Treasury bond fund to limit that volatility. A bond fund might hold 10 precent of your contributions when you are young, you should slowly increase that percentage as you get closer to retirement.

A bond fund added to your investments will moderate your returns.

2. The target date fund

Try a target date fund (TDF) if you want something more simple than the index fund portfolio. TDFs combine bonds and stocks into one fund.

The composition of bonds and stocks in a Target Date Fund is made to work with your retirement timeline. That means you do not have to change your portfolio to be more conservative as you age. The fund automatically does this for you.

Your 401(k) most likely offers you one set of TDFs with many vintages. The vintage — the date in the fund name — should match the retirement year you have planned.

It is smart to take an extra step and review the fund documentation. You should watch how the fund moves from aggressive to conservative over a period of time. If that change feels too aggressive or conservative, you can pick a different vintage. A fund with a target year that is later would be more aggressive. To be more conservative you would select an earlier vintage.

Building an above-average retirement

Earning wealth for retirement takes some time, however it does not have to be complicated or hard. A single TDF or a portfolio of two index funds can do the job.

If you think the idea of retiring as a millionaire is appealing you should make sure to check your 401k investment selections and plan on looking over your account’s performance regularly. The progress may be slow at the beginning but continue with your plan and it will pay off.

Author: Blake Ambrose

When Elon Musk tweets, crypto traders pay attention. The Space X and Tesla CEO has actually long been a vocal supporter of cryptocurrencies.

In some cases, though, cryptocurrency traders might focus too much on Musk. For instance, when Musk tweets photos of his Shiba Inu puppy, the value of digital coin Shiba Inu has a tendancy to rise. Does a picture of a billionaire’s dog truly make the crypto more valuable? Of course not.

Here are the only cryptos Musk actually owns.

1. Bitcoin

Previously this year, Tesla revealed that it purchased $1.5 billion of Bitcoin. It also started accepting the crypto as payment for its electric vehicles. That lasted just a couple of months, though, due to concerns regarding the energy consumption required to mine Bitcoin. Musk later stated that Tesla will probably resume accepting the crypto.

For a long period of time, Musk had only a modest position in Bitcoin. As recently as early 2019, Musk said that he had just 0.25 Bitcoins that were provided to him by a buddy. However, he verified over the summer that BTC is his largest crypto holding and intends to hold it for the long term.

2. Dogecoin

Musk has pretty much become the public face of Dogecoin. His connections to the crypto go back at the very least three years. In 2018, he reached out to Doge creator Jackson Palmer for assistance in removing scam bots from his Twitter page.

The next year, Musk disclosed in a tweet, “Dogecoin may be my favorite crypto. It is pretty great.” He also won the vote in an April Fool’s Day survey taken by Dogecoin’s main Twitter account asking which CEO would presumably be the ideal CEO for the cryptocurrency. Musk would later on briefly change his Twitter account to read “former CEO of Dogecoin.”

Still, Musk validated over the summer time that he personally owns Dogecoin. He stated that he supports it since it feels “like the people’s cryptocurrency.”

3. Ethereum

Musk’s initial public link with Ethereum was not a favorable one. One scam that was associated with Twitter users who impersonated well-known people supposedly gave out large quantities of Ether tokens.

His one-word tweet in April 2019 stating only “Ethereum” stoked interest in the crypto. It additionally triggered an online exchange between Musk and Ethereum co-founder Vitalik Buterin.

The subsequent year, however, Musk appeared to be undecided about Ethereum. He replied to a tweet from actor William Shatner, specifying, “I am not developing anything on ethereum. Not for or against it, just do not use it or own any.”

He now appears to have hopped off that fence. Previously this year, he revealed that he owns Ethereum tokens as well as Bitcoin and Dogecoin.

Author: Scott Dowdy

The stock market has had a good year, with the S&P 500 up by a huge 110% since prices went down in March 2020.

However, stock prices cannot keep going forever. Some experts think the market is now overvalued, and it could be due for a downturn sometime soon. Whether that will really happen, though, is anybody’s guess. The stock market is known for being unpredictable, and it is uncertain when prices will fall.

That said, it is normal to be worried about a crash. Although nobody knows for sure whether a crash is around the corner, there are some things you can do to prepare your own portfolio.

1. Ensure you are diversified

Diversification is important for building a stronger portfolio, and it can make a big difference when it comes to surviving volatility. The more companies you are investing in, the more your portfolio could come back after a market crash.

A diversified portfolio should have 10 to 15 stocks from various industries. To be safe, though, it could be wise to invest in 25 to 30 stocks at least from a variety of sectors.

2. Invest well for your age

When you have decades before your retirement, you can invest more aggressively. As long as you are buying good stocks and you have a portfolio that is diversified, there is a good chance your portfolio will come back eventually if the market falls.

If you are close to retirement age, though, it is a good idea to begin investing more conservatively. Depending on how many years you have left before retirement, you might not have the time to sit back and wait for your investments to return from a market collapse before you need the money.

3. Choose the best investments

The personal investments you go for will have a great effect on your portfolio’s numbers as well as its ability to come back from market downturns.

High-reward and high-risk investments might be tempting, but they are not for everyone. These stocks might perform well in the short term, but they usually struggle in the long term — especially if the markets are volatile.

A safer solution, then, is to put your money into solid companies with stronger underlying business numbers. These stocks likely will not experience large growth, but they do have a good chance of surviving a market downturn and bringing in positive returns long term.

The Motley Fool has a disclosure policy.

Author: Blake Ambrose

The demand for mobile towers is expected to keep rising along with the release of 5G wireless networks. By one estimate, the global 5G market that was at $41.48 billion last year is expected to see a compound yearly growth rate of 46.2% through the year 2028. There are numerous ways to invest in the wireless communications market, including the main cellphone companies. Let’s look at the mobile tower companies that the carriers use.

These three companies are real estate investment trusts, and all three combined own more than 75% of that vital infrastructure domestically.

American Tower is the biggest of all REITs

American Tower has been in existence since 1995 and has expanded into the biggest of U.S. REITs by market capitalization, at almost $130 billion. The company operates and owns over 183,000 communications sites around the world, as well as outdoor distributed antenna systems, in-building systems, managed rooftops, and services that speed up the rate of network deployment.

The company has expanded through acquisition and organically, most recently with the company purchasing the data center REIT CoreSite Realty, which adds multichannel integration and diversification to AMT’s portfolio, especially with its cloud storage capabilities.

AMT’s share price has increased by 186% over the last five years and is also yielding 1.91% from a dividend it has increased every quarter since the beginning of 2012, not too long after it became a REIT.

In its 3Q21 revenue call, the company stated it thinks mobile data usage will grow over 25% in the next five years, and the tenant billings to increase in the mid-single-digit range every year in the United States and higher abroad through the year 2027. Altogether, this means AMT traders can reasonably expect additional growth in share value and payout going forward.

Crown Castle grows its stake in all major U.S. markets

Along with around 40,000 cell towers, the portfolio of Houston-based Crown Castle has about 80,000 route miles of fiber and 80,000 small cell nodes and, and the company also claims a presence in all large U.S. markets.

In their October 21 earnings call, Jay Brown, Crown Castle CEO said that his company was hitting a “record level of activity” in not just the new upgrades of thousands of cell sites as part of its 5G rollout but also the tower co-location work that’s being done with DISH Network as that business builds a countrywide 5G network from nothing.

Crown Castle’s share price and yearly dividend payout have both skyrocketed in the last five years, from about $73 per share in mid-Dec. 2016 to about $200 presently, with $3.00 per share in dividends to $5.88 today, hikes of around 180% and 96%, respectively.

Brown said Crown Castle is “in a great position to capitalize on both the current environment and to increase our dividends and cash flows per share in the short term and for years into the future.” If that happens, that would be great news for buy-and-hold investors who get in now.

SBA Communications predicts high leasing demand in 2022 and beyond

SBA Communications has been here since 1989 as an operator and owner of wireless communication infrastructure, including buildings, rooftops, towers, small cells and distributed antenna systems in 14 markets throughout South Africa and the Americas.

In their 3Q2021 earnings call on November 1, CEO Jeffrey Stoops stated the company was seeing a record in service earnings and leasing and services backlogs at a multiyear high. He stated the company predicts “elevated leasing activities in the U.S. to remain through next year and perhaps longer.”

The stock price has almost quadrupled in the last four years and now has a price/revenue ratio of around 140, compared with S&P 500 which has ratio of 30. The dividend, meanwhile, has been increased 57% in the last two years from $0.37 to $0.58 per share, but it is still a highly expensive stock.

Author: Scott Dowdy

As 2021 nears an end, the world is getting ready for yet another pandemic year. The Covid-19 vaccine market is a battle over market share, amid the rise of the mysterious omicron strain.

So far, I think that the best vaccine stocks to invest in next year will be the same stocks as in 2021. The winners will most likely keep winning, and that means there is an opportunity for traders, even if they are showing up late. Let us look at the two vaccine stocks that skyrocketed the highest in 2021 and determine why next year may be more of the same.

1. Pfizer

It should not be too surprising for Pfizer to be seen as the best vaccine stock for next year and beyond. Its Comirnaty is the most widely approved in the world and the most bought by far, and nothing else even comes close to touching it. It held a 74% share of the United States market, and 80% of the Europe market as of Oct.

In total, management predicts as much as $36 billion in earnings from Comirnaty this year. In 2022, it expects around $29 billion, from the scheduled delivery of 1.7 billion doses of the vaccine. The fact that Pfizer may earn less from the vaccine next year than it did in 2021 should not scare investors, though.

The company is creating an antiviral pill for the COVID-19 virus called Paxlovid. On December 14, it confirmed the results of its newest phase 2/3 clinical trial, which has shown that adults that were treated with Paxlovid within five days of their first symptoms experienced an 88% lower risk of death or hospitalization when compared to placebo group. Pfizer has already shared the data with the FDA to help with the Emergency Use Authorization it applied for in Nov.

And the United States government has made a deal to purchase 10 million courses of the medication for $5.3 billion, which will be delivered in 2022. So even if Comirnaty earnings scales down next year, Paxlovid income might just be getting started, and that is another reason that Pfizer is the top COVID treatment stock.

2. Moderna

Moderna (NASDAQ:MRNA) is my choice for the second-best vaccine stock next year. Moderna predicts earnings between $15 billion to $18 billion from its Spikevax this year, with about 800 million doses delivered. Next year, depending on the strength of demand, that might reach as much as $22 billion.

In terms of how many doses are committed in existing supply deals, Pfizer is the No. 1, followed by the Serum Institute of India, according to data from Unicef. Moderna is the No. 3 in the world, making its vaccine much more in-demand than those of AstraZeneca and Johnson & Johnson. As its jab continues to be effective over time, the company’s overall performance against these two bigger competitors keeps improving, though it is not gaining any ground against its competitor Pfizer.

Moderna plans to make a pan-respiratory vaccine that could be administered as a yearly booster shot. Though the Moderna’s precursor vaccines to prevent any illnesses caused by influenza, coronavirus variants, the cytomegalovirus, and respiratory syncytial virus remain in clinical trials, the payoff might eventually be huge.

In effect, Moderna might one day dominate the global market for a yearly vaccine against the most common viral respiratory diseases. And that would be an opportunity worth billions, which is exciting for investors.

Author: Steven Sinclaire

Ad Blocker Detected!

Advertisements fund this website. Please disable your adblocking software or whitelist our website.
Thank You!